{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:40:04Z","timestamp":1786981204768,"version":"build-2736575974"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-024-10478-8","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T15:32:46Z","timestamp":1735313566000},"page":"477-491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epicardial adipose tissue: a new link between type 2 diabetes and heart failure\u2014a comprehensive review"],"prefix":"10.1007","volume":"30","author":[{"given":"Si-jia","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-lian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-xi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-ping","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-jiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"10478_CR1","doi-asserted-by":"crossref","unstructured":"Laakso M (2019) Biomarkers for type 2 diabetes. Mol Metab 27(2212\u20138778 (Electronic)):S139-S146.","DOI":"10.1016\/j.molmet.2019.06.016"},{"key":"10478_CR2","doi-asserted-by":"crossref","unstructured":"Seferovi\u0107 PM, Paulus WJ, Rosano G, et al (2024) Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases. Eur J Heart Fail (1879\u20130844 (Electronic)):22(21):45.","DOI":"10.1002\/ejhf.3347"},{"issue":"1","key":"10478_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","volume":"61","author":"GH Jia","year":"2018","unstructured":"Jia GH, Whaley-Connell A, Sowers JR (2018) Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetol 61(1):21\u201328","journal-title":"Diabetol"},{"issue":"1","key":"10478_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","volume":"117","author":"L van Heerebeek","year":"2008","unstructured":"van Heerebeek L, Hamdani N, Handoko ML et al (2008) Diastolic stiffness of the failing diabetic heart. Circ 117(1):43\u201351","journal-title":"Circ"},{"issue":"6","key":"10478_CR5","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.2337\/db15-0568","volume":"65","author":"B Vulesevic","year":"2016","unstructured":"Vulesevic B, McNeill B, Giacco F et al (2016) Methylglyoxal-induced endothelial cell loss and inflammation contribute to the development of diabetic cardiomyopathy. Diabetes 65(6):1699\u20131713","journal-title":"Diabetes"},{"issue":"5","key":"10478_CR6","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1161\/CIRCULATIONAHA.123.064719","volume":"150","author":"M Katoh","year":"2024","unstructured":"Katoh M, Nomura S, Yamada S et al (2024) Vaccine therapy for heart failure targeting the inflammatory cytokine Igfbp7. Circ 150(5):374\u2013389","journal-title":"Circ"},{"issue":"1","key":"10478_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12933-023-01778-8","volume":"22","author":"J Liu","year":"2023","unstructured":"Liu J, Yu Q, Li Z et al (2023) Epicardial adipose tissue density is a better predictor of cardiometabolic risk in HFpEF patients: a prospective cohort study. Cardiovasc Diabetol 22(1):45","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10478_CR8","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1002\/ejhf.2709","volume":"24","author":"A Venkateshvaran","year":"2022","unstructured":"Venkateshvaran A, Faxen UL, Hage C et al (2022) Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS-HFpEF study. Eur J Heart Fail 24(12):2251\u20132260","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10478_CR9","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1002\/ehf2.14483","volume":"10","author":"VA Rossi","year":"2023","unstructured":"Rossi VA, Nebunu D, Haider T et al (2023) Diverging role of epicardial adipose tissue across the entire heart failure spectrum. ESC Heart Fail 10(6):3419\u20133429","journal-title":"ESC Heart Fail"},{"key":"10478_CR10","doi-asserted-by":"crossref","unstructured":"Koepp KE, Obokata M, Reddy YNV, Olson TP, Borlaug BA (2020) Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction. JACC: Heart Fail\u00a08(8):657\u2013666.","DOI":"10.1016\/j.jchf.2020.04.016"},{"issue":"3","key":"10478_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/ejhf.1617","volume":"22","author":"CK Wu","year":"2020","unstructured":"Wu CK, Lee JK, Hsu JC et al (2020) Myocardial adipose deposition and the development of heart failure with preserved ejection fraction. Eur J Heart Fail 22(3):445\u2013454","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10478_CR12","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/ejhf.2337","volume":"23","author":"NR Pugliese","year":"2021","unstructured":"Pugliese NR, Paneni F, Mazzola M et al (2021) Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure. Eur J Heart Fail 23(11):1858\u20131871","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10478_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","volume":"136","author":"M Obokata","year":"2017","unstructured":"Obokata M, Reddy YNV, Pislaru SV, Melenovsky V, Borlaug BA (2017) Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circ 136(1):6\u201319","journal-title":"Circ"},{"key":"10478_CR14","doi-asserted-by":"crossref","unstructured":"Borlaug BA, Reddy YNV (2019) The role of the pericardium in heart failure. JACC: Heart Failure\u00a07(7):574\u2013585.","DOI":"10.1016\/j.jchf.2019.03.021"},{"issue":"1","key":"10478_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12933-021-01237-2","volume":"20","author":"B Gaborit","year":"2021","unstructured":"Gaborit B, Ancel P, Abdullah AE et al (2021) Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study. Cardiovasc Diabetol 20(1):57","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"10478_CR16","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/ejhf.1596","volume":"21","author":"SD Anker","year":"2019","unstructured":"Anker SD, Butler J, Filippatos GS et al (2019) Evaluation of the effects of sodium\u2013glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial. Eur J Heart Fail 21(10):1279\u20131287","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10478_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/ijo.2011.117","volume":"36","author":"B Gaborit","year":"2012","unstructured":"Gaborit B, Kober F, Jacquier A et al (2012) Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat. Int J Obesity 36(3):422\u2013430","journal-title":"Int J Obesity"},{"issue":"15","key":"10478_CR18","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.jacc.2012.06.016","volume":"60","author":"B Gaborit","year":"2012","unstructured":"Gaborit B, Jacquier A, Kober F et al (2012) Effects of bariatric surgery on cardiac ectopic fat lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content. J Am Coll Cardiol 60(15):1381\u20131389","journal-title":"J Am Coll Cardiol"},{"key":"10478_CR19","doi-asserted-by":"crossref","unstructured":"Iacobellis G, Basilico S, Malavazos AE. Targeting epicardial fat in obesity and diabetes pharmacotherapy. 2022;274(0171\u20132004 (Print)):93\u2013108.","DOI":"10.1007\/164_2021_577"},{"issue":"38","key":"10478_CR20","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1093\/eurheartj\/ehad484","volume":"44","author":"C Antoniades","year":"2023","unstructured":"Antoniades C, Tousoulis D, Vavlukis M et al (2023) Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers: a clinical consensus statement from the European Society of Cardiology Working Group on Coronary Pathophysiology and Micro-circulation. Eur Heart J 44(38):3827\u20133844","journal-title":"Eur Heart J"},{"issue":"10","key":"10478_CR21","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/ncpcardio0319","volume":"2","author":"G Iacobellis","year":"2005","unstructured":"Iacobellis G, Corradi D, Sharma AM (2005) Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Card 2(10):536\u2013543","journal-title":"Nat Clin Pract Card"},{"issue":"6","key":"10478_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nrendo.2015.58","volume":"11","author":"G Iacobellis","year":"2015","unstructured":"Iacobellis G (2015) Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol 11(6):363\u2013371","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"10478_CR23","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","volume":"19","author":"G Iacobellis","year":"2022","unstructured":"Iacobellis G (2022) Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol 19(9):593\u2013606","journal-title":"Nat Rev Cardiol"},{"key":"10478_CR24","doi-asserted-by":"crossref","unstructured":"R\u00e4m\u00f6 JT, Kany S, Hou CR, et al (2024) Cardiovascular significance and genetics of epicardial and pericardial adiposity. JAMA Cardiol\u00a09(5).","DOI":"10.1001\/jamacardio.2024.0080"},{"key":"10478_CR25","doi-asserted-by":"crossref","unstructured":"Che\u0142adze P, Martuszewski A, Por\u0119ba R, Ga\u0107 P (2022) The importance of the assessment of epicardial adipose tissue in scientific research. J Clin Med\u00a011(19).","DOI":"10.3390\/jcm11195621"},{"issue":"7","key":"10478_CR26","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.3390\/ijms24076838","volume":"24","author":"VA Rossi","year":"2023","unstructured":"Rossi VA, Gruebler M, Monzo L, Galluzzo A, Beltrami M (2023) The different pathways of epicardial adipose tissue across the heart failure phenotypes: from pathophysiology to therapeutic target. Int J Mol Sci 24(7):6838","journal-title":"Int J Mol Sci"},{"key":"10478_CR27","doi-asserted-by":"crossref","unstructured":"Mukherjee AG, Renu K, Gopalakrishnan AV, et al (2023) Epicardial adipose tissue and cardiac lipotoxicity: a review. Life Sci\u00a0328(1879\u20130631 (Electronic)):121913.","DOI":"10.1016\/j.lfs.2023.121913"},{"issue":"6","key":"10478_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1515\/jbcpp-2022-0230","volume":"33","author":"V Patel","year":"2022","unstructured":"Patel V, Patel J (2022) Cellular cross talk between epicardial fat and cardiovascular risk. J Basic Clin Physiol Pharmacol 33(6):683\u2013694","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"10478_CR29","doi-asserted-by":"crossref","unstructured":"Guglielmo M, Lin A, Dey D, et al (2021) Epicardial fat and coronary artery disease: role of cardiac imaging. Atheroscler 321(1879\u20131484 (Electronic)):30\u201338.","DOI":"10.1016\/j.atherosclerosis.2021.02.008"},{"issue":"1","key":"10478_CR30","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1186\/s12967-023-04518-4","volume":"21","author":"TB Opstad","year":"2023","unstructured":"Opstad TB, Papotti B, \u00c5kra S et al (2023) Sirtuin1, not NAMPT, possesses anti-inflammatory effects in epicardial, pericardial and subcutaneous adipose tissue in patients with CHD. J Transl Med 21(1):644","journal-title":"J Transl Med"},{"issue":"8","key":"10478_CR31","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/eurjpc\/zwad050","volume":"30","author":"AE Malavazos","year":"2023","unstructured":"Malavazos AE, Iacobellis G, Dozio E et al (2023) Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies. Eur J Prev Cardiol 30(8):680\u2013693","journal-title":"Eur J Prev Cardiol"},{"key":"10478_CR32","doi-asserted-by":"crossref","unstructured":"Zhang X-Z, Chen X-L, Tang T-T, et al (2023) T lymphocyte characteristics and immune repertoires in the epicardial adipose tissue of heart failure patients. Front Immunol\u00a014(1664\u20133224 (Electronic)):1126997.","DOI":"10.3389\/fimmu.2023.1126997"},{"issue":"16","key":"10478_CR33","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.145495","volume":"6","author":"V Vyas","year":"2021","unstructured":"Vyas V, Blythe H, Wood EG et al (2021) Obesity and diabetes are major risk factors for epicardial adipose tissue inflammation. Jci Insight 6(16)","journal-title":"Jci Insight"},{"issue":"3","key":"10478_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jacc.2011.01.048","volume":"58","author":"Y Hirata","year":"2011","unstructured":"Hirata Y, Tabata M, Kurobe H et al (2011) Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol 58(3):248\u2013255","journal-title":"J Am Coll Cardiol"},{"key":"10478_CR35","doi-asserted-by":"crossref","unstructured":"Baker AR, da Silva NF, Quinn DW, et al (2006) Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetology\u00a05(1475\u20132840 (Electronic)):1.","DOI":"10.1186\/1475-2840-5-1"},{"key":"10478_CR36","doi-asserted-by":"crossref","unstructured":"Willar B, Tran K-V, Fitzgibbons TP (2023) Epicardial adipocytes in the pathogenesis of atrial fibrillation: an update on basic and translational studies. Front Endocrinol\u00a014(1664\u20132392 (Print)):1154824.","DOI":"10.3389\/fendo.2023.1154824"},{"issue":"12","key":"10478_CR37","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1113\/JP273049","volume":"595","author":"AS Antonopoulos","year":"2017","unstructured":"Antonopoulos AS, Antoniades C (2017) The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles. J Physiol 595(12):3907\u20133917","journal-title":"J Physiol"},{"issue":"12","key":"10478_CR38","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1080\/14779072.2016.1256773","volume":"14","author":"A Gastaldelli","year":"2016","unstructured":"Gastaldelli A, Gaggini M (2016) Ectopic fat: a target for cardiometabolic risk management. Expert Rev Cardiovasc Ther 14(12):1301\u20131303","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"1","key":"10478_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12933-019-0807-3","volume":"18","author":"Y Li","year":"2019","unstructured":"Li Y, Liu B, Li Y et al (2019) Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Diabetol 18(1):3","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10478_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4093\/dmj.2015.39.5.405","volume":"39","author":"DK Song","year":"2015","unstructured":"Song DK, Hong YS, Lee H, Oh J-Y, Sung Y-A, Kim Y (2015) Increased epicardial adipose tissue thickness in type 2 diabetes mellitus and obesity. Diabetes Metab J 39(5):405\u2013413","journal-title":"Diabetes Metab J"},{"issue":"1","key":"10478_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00592-012-0436-8","volume":"51","author":"L Nasarre","year":"2012","unstructured":"Nasarre L, Juan-Babot O, Gastelurrutia P et al (2012) Low density lipoprotein receptor\u2013related protein 1 is upregulated in epicardial fat from type 2 diabetes mellitus patients and correlates with glucose and triglyceride plasma levels. Acta Diabetol 51(1):23\u201330","journal-title":"Acta Diabetol"},{"issue":"12","key":"10478_CR42","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1111\/echo.12960","volume":"32","author":"AN Aslan","year":"2015","unstructured":"Aslan AN, Kele\u015f T, Ayhan H et al (2015) The relationship between epicardial fat thickness and endothelial dysfunction in type I diabetes mellitus. Echocardiography 32(12):1745\u20131753","journal-title":"Echocardiography"},{"issue":"1","key":"10478_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jacc.2016.03.597","volume":"68","author":"E Levelt","year":"2016","unstructured":"Levelt E, Pavlides M, Banerjee R et al (2016) Ectopic and visceral fat deposition in lean and obese patients with type 2 diabetes. J Am Coll Cardiol 68(1):53\u201363","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10478_CR44","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.1210\/jc.2006-0584","volume":"91","author":"M Kankaanp\u00e4\u00e4","year":"2006","unstructured":"Kankaanp\u00e4\u00e4 M, Lehto H-R, P\u00e4rkk\u00e4 JP et al (2006) Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 91(11):4689\u20134695","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10478_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.101841","volume":"48","author":"AS Antonopoulos","year":"2023","unstructured":"Antonopoulos AS, Papastamos C, Cokkinos DV, Tsioufis K, Tousoulis D (2023) Epicardial adipose tissue in myocardial disease: from physiology to heart failure phenotypes. Curr Probl Cardiol 48(10)","journal-title":"Curr Probl Cardiol"},{"key":"10478_CR46","doi-asserted-by":"crossref","unstructured":"Lai Y-H, Liu LY-m, Sung K-T, et al (2021) Diverse adiposity and atrio-ventricular dysfunction across obesity phenotypes: implication of epicardial fat analysis. Diagn\u00a011(3):408.","DOI":"10.3390\/diagnostics11030408"},{"issue":"5","key":"10478_CR47","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1161\/CIRCRESAHA.115.307856","volume":"118","author":"AS Antonopoulos","year":"2016","unstructured":"Antonopoulos AS, Margaritis M, Verheule S et al (2016) Mutual regulation of epicardial adipose tissue and myocardial redox state by PPAR-\u03b3\/adiponectin signalling. Circ Res 118(5):842\u2013855","journal-title":"Circ Res"},{"key":"10478_CR48","doi-asserted-by":"crossref","unstructured":"Kotha S, Plein S, Greenwood JP, Levelt E (2024) Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging \u2013 a narrative review. The Adv Endocrinol Metab\u00a015(2042\u20130188 (Print)):20420188241229540.","DOI":"10.1177\/20420188241229540"},{"issue":"6","key":"10478_CR49","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1210\/jcem.86.6.7553","volume":"86","author":"D Manzella","year":"2001","unstructured":"Manzella D, Barbieri M, Rizzo MR et al (2001) Role of free fatty acids on cardiac autonomic nervous system in noninsulin-dependent diabetic patients: effects of metabolic control. J Clin Endocrinol Metab 86(6):2769\u20132774","journal-title":"J Clin Endocrinol Metab"},{"key":"10478_CR50","doi-asserted-by":"crossref","unstructured":"Chahine Y, Askari-Atapour B, Kwan KT, et al (2022) Epicardial adipose tissue is associated with left atrial volume and fibrosis in patients with atrial fibrillation. Front Cardiovasc Medicine\u00a09(2297\u2013055X (Print)):1045730.","DOI":"10.3389\/fcvm.2022.1045730"},{"issue":"2","key":"10478_CR51","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/ejhf.1646","volume":"22","author":"M Packer","year":"2019","unstructured":"Packer M (2019) Do most patients with obesity or type 2 diabetes, and atrial fibrillation, also have undiagnosed heart failure? A critical conceptual framework for understanding mechanisms and improving diagnosis and treatment. Eur J Heart Fail 22(2):214\u2013227","journal-title":"Eur J Heart Fail"},{"key":"10478_CR52","doi-asserted-by":"crossref","unstructured":"Batal O, Schoenhagen P, Shao M, et al (2010) Left atrial epicardial adiposity and atrial fibrillation. Circ:Arrhythmia and Electrophysiol\u00a03(3):230\u2013236.","DOI":"10.1161\/CIRCEP.110.957241"},{"issue":"2","key":"10478_CR53","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10840-016-0130-9","volume":"47","author":"K Takahashi","year":"2016","unstructured":"Takahashi K, Okumura Y, Watanabe I et al (2016) Anatomical proximity between ganglionated plexi and epicardial adipose tissue in the left atrium: implication for 3D reconstructed epicardial adipose tissue-based ablation. J Interv Card Electrophysiol 47(2):203\u2013212","journal-title":"J Interv Card Electrophysiol"},{"issue":"10","key":"10478_CR54","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1161\/CIRCRESAHA.119.316251","volume":"126","author":"N Suffee","year":"2020","unstructured":"Suffee N, Moore-Morris T, Jagla B et al (2020) Reactivation of the epicardium at the origin of myocardial fibro-fatty infiltration during the atrial cardiomyopathy. Circ Res 126(10):1330\u20131342","journal-title":"Circ Res"},{"issue":"11","key":"10478_CR55","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/ejhf.1283","volume":"20","author":"G van Woerden","year":"2018","unstructured":"van Woerden G, Gorter TM, Westenbrink BD, Willems TP, van Veldhuisen DJ, Rienstra M (2018) Epicardial fat in heart failure patients with mid-range and preserved ejection fraction. Eur J Heart Fail 20(11):1559\u20131566","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10478_CR56","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.amjcard.2014.08.037","volume":"114","author":"R Fontes-Carvalho","year":"2014","unstructured":"Fontes-Carvalho R, Fontes-Oliveira M, Sampaio F et al (2014) Influence of epicardial and visceral fat on left ventricular diastolic and systolic functions in patients after myocardial infarction. Am J Cardiol 114(11):1663\u20131669","journal-title":"Am J Cardiol"},{"key":"10478_CR57","doi-asserted-by":"crossref","unstructured":"Doesch C, Haghi D, Fl\u00fcchter S, et al (2010) Epicardial adipose tissue in patients with heart failure. J Cardiovasc Magn Reson\u00a012(1).","DOI":"10.1186\/1532-429X-12-40"},{"issue":"3","key":"10478_CR58","doi-asserted-by":"publisher","first-page":"E253","DOI":"10.1002\/oby.20149","volume":"21","author":"C Doesch","year":"2013","unstructured":"Doesch C, Streitner F, Bellm S et al (2013) Epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure due to dilated cardiomyopathy. Obesity 21(3):E253\u2013E261","journal-title":"Obesity"},{"key":"10478_CR59","doi-asserted-by":"crossref","unstructured":"Zhang XZ, Chen XL, Tang TT, et al (2023) T lymphocyte characteristics and immune repertoires in the epicardial adipose tissue of heart failure patients. Front Immunol\u00a014(1664\u20133224 (Electronic)):1126997.","DOI":"10.3389\/fimmu.2023.1126997"},{"key":"10478_CR60","doi-asserted-by":"crossref","unstructured":"Gruzdeva O, Uchasova E, Dyleva Y, et al (2019) Adipocytes directly affect coronary artery disease pathogenesis via induction of adipokine and cytokine imbalances. Frontiers in Immunology\u00a010(1664\u20133224 (Electronic)):2163.","DOI":"10.3389\/fimmu.2019.02163"},{"issue":"1","key":"10478_CR61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/eci.12186","volume":"44","author":"RM Agra","year":"2014","unstructured":"Agra RM, Teijeira-Fern\u00e1ndez E, Pascual-Figal D et al (2014) Adiponectin and p53 mRNA in epicardial and subcutaneous fat from heart failure patients. Eur J Clin Invest 44(1):29\u201337","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"10478_CR62","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.cardfail.2015.07.014","volume":"21","author":"LE Fosshaug","year":"2015","unstructured":"Fosshaug LE, Dahl CP, Risnes I et al (2015) Altered levels of fatty acids and inflammatory and metabolic mediators in epicardial adipose tissue in patients with systolic heart failure. J Card Fail 21(11):916\u2013923","journal-title":"J Card Fail"},{"issue":"1","key":"10478_CR63","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/jcmm.14758","volume":"24","author":"L Zhao","year":"2020","unstructured":"Zhao L, Guo ZS, Wang P et al (2020) Proteomics of epicardial adipose tissue in patients with heart failure. J Cell Mol Med 24(1):511\u2013520","journal-title":"J Cell Mol Med"},{"issue":"8","key":"10478_CR64","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1161\/CIRCRESAHA.116.308621","volume":"118","author":"IA White","year":"2016","unstructured":"White IA (2016) Cardiac sympathetic denervation in the failing heart: a role for epicardial adipose tissue. Circ Res 118(8):1189\u20131191","journal-title":"Circ Res"},{"issue":"6","key":"10478_CR65","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jacl.2017.08.018","volume":"11","author":"CK Wu","year":"2017","unstructured":"Wu CK, Tsai HY, Su MYM et al (2017) Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients. J Clin Lipidol 11(6):1421\u20131431","journal-title":"J Clin Lipidol"},{"issue":"3","key":"10478_CR66","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.numecd.2015.12.005","volume":"26","author":"E Vianello","year":"2016","unstructured":"Vianello E, Dozio E, Arnaboldi F et al (2016) Epicardial adipocyte hypertrophy: association with M1-polarization and toll-like receptor pathways in coronary artery disease patients. Nutr Metab Cardiovas 26(3):246\u2013253","journal-title":"Nutr Metab Cardiovas"},{"issue":"20","key":"10478_CR67","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1161\/01.CIR.0000099542.57313.C5","volume":"108","author":"T Mazurek","year":"2003","unstructured":"Mazurek T, Zhang LF, Zalewski A et al (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108(20):2460\u20132466","journal-title":"Circulation"},{"key":"10478_CR68","doi-asserted-by":"crossref","unstructured":"Mr\u00e1z M, Cinkajzlov\u00e1 A, Klou\u010dkov\u00e1 J, et al (2019) Dendritic cells in subcutaneous and epicardial adipose tissue of subjects with type 2 diabetes, obesity, and coronary artery disease. Mediat Inflamm\u00a0(1466\u20131861 (Electronic)):1\u20137.","DOI":"10.1155\/2019\/5481725"},{"key":"10478_CR69","doi-asserted-by":"crossref","unstructured":"Reinisch I, Klymiuk I, Michenthaler H, et al (2022) p53 Regulates a miRNA-fructose transporter axis in brown adipose tissue under fasting. Front Genet 13(1664\u20138021 (Print)):2622.","DOI":"10.3389\/fgene.2022.913030"},{"issue":"6","key":"10478_CR70","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/oby.21059","volume":"23","author":"EA McAninch","year":"2015","unstructured":"McAninch EA, Fonseca TL, Poggioli R et al (2015) Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease. Obesity 23(6):1267\u20131278","journal-title":"Obesity"},{"key":"10478_CR71","doi-asserted-by":"crossref","unstructured":"Iacobellis G, Barbaro G (2019) Epicardial adipose tissue feeding and overfeeding the heart. Nutr\u00a059(1873\u20131244 (Electronic)):1\u20136.","DOI":"10.1016\/j.nut.2018.07.002"},{"issue":"2","key":"10478_CR72","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000582","volume":"3","author":"TP Fitzgibbons","year":"2014","unstructured":"Fitzgibbons TP, Czech MP (2014) Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations. J Am Heart Assoc 3(2)","journal-title":"J Am Heart Assoc"},{"issue":"13","key":"10478_CR73","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/eurheartj\/eht099","volume":"36","author":"N Venteclef","year":"2015","unstructured":"Venteclef N, Guglielmi V, Balse E et al (2015) Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J 36(13):795\u2013805","journal-title":"Eur Heart J"},{"issue":"20","key":"10478_CR74","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","volume":"71","author":"M Packer","year":"2018","unstructured":"Packer M (2018) Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. J Am Coll Cardiol 71(20):2360\u20132372","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10478_CR75","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","volume":"131","author":"SF Mohammed","year":"2015","unstructured":"Mohammed SF, Hussain S, Mirzoyev SA, Edwards WD, Maleszewski JJ, Redfield MM (2015) Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Circ 131(6):550\u2013559","journal-title":"Circ"},{"issue":"4","key":"10478_CR76","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1177\/1479164115579006","volume":"12","author":"CSP Lam","year":"2015","unstructured":"Lam CSP (2015) Diabetic cardiomyopathy: an expression of stage B heart failure with preserved ejection fraction. Diab Vasc Dis Res 12(4):234\u2013238","journal-title":"Diab Vasc Dis Res"},{"key":"10478_CR77","doi-asserted-by":"crossref","unstructured":"Elsanhoury A, Nelki V, Kelle S, Van Linthout S, Tsch\u00f6pe C. Epicardial fat expansion in diabetic and obese patients with heart failure and preserved ejection fraction\u2014a specific HFpEF phenotype. Frontiers in Cardiovascular Medicine. 2021;8(2297\u2013055X (Print)):720690.","DOI":"10.3389\/fcvm.2021.720690"},{"key":"10478_CR78","doi-asserted-by":"crossref","unstructured":"Christensen RH, von Scholten BJ, Lehrskov LL, Rossing P, J\u00f8rgensen PG (2020) Epicardial adipose tissue: an emerging biomarker of cardiovascular complications in type 2 diabetes? Ther Adv Endocrinol Metabol11(2042\u20130188 (Print)):2042018820928824.","DOI":"10.1177\/2042018820928824"},{"key":"10478_CR79","doi-asserted-by":"crossref","unstructured":"Conte M, Petraglia L, Cabaro S, et al (2022) Epicardial adipose tissue and cardiac arrhythmias: focus on atrial fibrillation. Front Cardiovasc Med\u00a09(2297\u2013055X (Print)):932262.","DOI":"10.3389\/fcvm.2022.932262"},{"issue":"8","key":"10478_CR80","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/europace\/euac015","volume":"24","author":"AL Poggi","year":"2022","unstructured":"Poggi AL, Gaborit B, Schindler TH, Liberale L, Montecucco F, Carbone F (2022) Epicardial fat and atrial fibrillation: the perils of atrial failure. EP Europace 24(8):1201\u20131212","journal-title":"EP Europace"},{"issue":"9","key":"10478_CR81","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13277","volume":"22","author":"M Couselo-Seijas","year":"2021","unstructured":"Couselo-Seijas M, Rodr\u00edguez-Ma\u00f1ero M, Gonz\u00e1lez-Juanatey JR, Eiras S (2021) Updates on epicardial adipose tissue mechanisms on atrial fibrillation. Obes Rev 22(9)","journal-title":"Obes Rev"},{"key":"10478_CR82","doi-asserted-by":"crossref","unstructured":"Lorenzo-Almor\u00f3s A, Casado Cerrada J, \u00c1lvarez-Sala Walther L-A, M\u00e9ndez Bail\u00f3n M, Lorenzo Gonz\u00e1lez \u00d3 (2023) Atrial fibrillation and diabetes mellitus: dangerous liaisons or innocent bystanders? J Clin Med\u00a012(8).","DOI":"10.3390\/jcm12082868"},{"issue":"23","key":"10478_CR83","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.3390\/ijms20235981","volume":"20","author":"F Carbone","year":"2019","unstructured":"Carbone F, Lattanzio MS, Minetti S et al (2019) Circulating CRP levels are associated with epicardial and visceral fat depots in women with metabolic syndrome criteria. Int J Mol Sci 20(23):5981","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10478_CR84","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccep.2020.11.006","volume":"13","author":"R Mahajan","year":"2021","unstructured":"Mahajan R, Wong CX (2021) Obesity and metabolic syndrome in atrial fibrillation. Cardiac Electrophysiology Clinics 13(1):77\u201386","journal-title":"Cardiac Electrophysiology Clinics"},{"issue":"1","key":"10478_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2015.04.058","volume":"66","author":"R Mahajan","year":"2015","unstructured":"Mahajan R, Lau DH, Brooks AG et al (2015) Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J Am Coll Cardiol 66(1):1\u201311","journal-title":"J Am Coll Cardiol"},{"key":"10478_CR86","doi-asserted-by":"crossref","unstructured":"Mahajan R, Nelson A, Pathak RK, et al (2018) Electroanatomical remodeling of the atria in obesity. JACC: Clin Electrophysiol\u00a04(12):1529\u20131540.","DOI":"10.1016\/j.jacep.2018.08.014"},{"issue":"2","key":"10478_CR87","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/cvr\/cvu045","volume":"102","author":"SN Hatem","year":"2014","unstructured":"Hatem SN, Sanders P (2014) Epicardial adipose tissue and atrial fibrillation. Cardiovasc Res 102(2):205\u2013213","journal-title":"Cardiovasc Res"},{"issue":"11","key":"10478_CR88","doi-asserted-by":"publisher","first-page":"E368","DOI":"10.1210\/jc.2010-0780","volume":"95","author":"AL Schafer","year":"2010","unstructured":"Schafer AL, Vittinghoff E, Lang TF et al (2010) Fat infiltration of muscle, diabetes, and clinical fracture risk in older adults. J Clin Endocrinol Metab 95(11):E368\u2013E372","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10478_CR89","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1038\/s41467-023-40596-0","volume":"14","author":"A Lluch","year":"2023","unstructured":"Lluch A, Latorre J, Serena-Maione A et al (2023) Impaired Plakophilin-2 in obesity breaks cell cycle dynamics to breed adipocyte senescence. Nat Commun 14(1):5106","journal-title":"Nat Commun"},{"issue":"12","key":"10478_CR90","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/eurheartj\/ehab772","volume":"43","author":"M Cerrone","year":"2022","unstructured":"Cerrone M, Marr\u00f3n-Li\u00f1ares GM, van Opbergen CJM et al (2022) Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study. Eur Heart J 43(12):1251\u20131264","journal-title":"Eur Heart J"},{"issue":"7","key":"10478_CR91","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.3390\/ijms21072632","volume":"21","author":"L Opazo-R\u00edos","year":"2020","unstructured":"Opazo-R\u00edos L, Mas S, Mar\u00edn-Royo G et al (2020) Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities. Int J Mol Sci 21(7):2632","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10478_CR92","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/dom.14861","volume":"25","author":"L Nesti","year":"2022","unstructured":"Nesti L, Pugliese NR, Chiriac\u00f2 M, Trico D, Baldi S, Natali A (2022) Epicardial adipose tissue thickness is associated with reduced peak oxygen consumption and systolic reserve in patients with type 2 diabetes and normal heart function. Diabetes Obes Metab 25(1):177\u2013188","journal-title":"Diabetes Obes Metab"},{"key":"10478_CR93","doi-asserted-by":"crossref","unstructured":"Han Y, Ferrari VA (2013) Fatty heart and subclinical left ventricular dysfunction. Circ: Cardiovasc Imaging\u00a06(5):614\u2013616.","DOI":"10.1161\/CIRCIMAGING.113.000973"},{"issue":"7","key":"10478_CR94","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.3390\/ijms23073587","volume":"23","author":"K Nakamura","year":"2022","unstructured":"Nakamura K, Miyoshi T, Yoshida M et al (2022) Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus. Int J Mol Sci 23(7):3587","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10478_CR95","doi-asserted-by":"publisher","first-page":"21630","DOI":"10.1002\/jcp.28821","volume":"234","author":"D Ferrara","year":"2019","unstructured":"Ferrara D, Montecucco F, Dallegri F, Carbone F (2019) Impact of different ectopic fat depots on cardiovascular and metabolic diseases. J Cell Physiol 234(12):21630\u201321641","journal-title":"J Cell Physiol"},{"issue":"9","key":"10478_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109190","volume":"35","author":"D Khan","year":"2021","unstructured":"Khan D, Ara T, Ravi V et al (2021) SIRT6 transcriptionally regulates fatty acid transport by suppressing PPAR\u03b3. Cell Rep 35(9)","journal-title":"Cell Rep"},{"issue":"4","key":"10478_CR97","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s12276-023-00958-6","volume":"55","author":"TK Pham","year":"2023","unstructured":"Pham TK, Nguyen THT, Yi JM et al (2023) Evogliptin, a DPP-4 inhibitor, prevents diabetic cardiomyopathy by alleviating cardiac lipotoxicity in db\/db mice. Exp Mol Med 55(4):767\u2013778","journal-title":"Exp Mol Med"},{"issue":"4","key":"10478_CR98","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.tcm.2012.07.003","volume":"22","author":"C Riehle","year":"2012","unstructured":"Riehle C, Abel ED (2012) PGC-1 proteins and heart failure. Trends Cardiovasc Med 22(4):98\u2013105","journal-title":"Trends Cardiovasc Med"},{"key":"10478_CR99","doi-asserted-by":"crossref","unstructured":"Lasheras J, Vil\u00e0 M, Zamora M, et al ( 2016) Gene expression profiling in hearts of diabetic mice uncovers a potential role of estrogen-related receptor \u03b3 in diabetic cardiomyopathy. Mol Cell Endocrinol 430(1872\u20138057 (Electronic)):77\u201388.","DOI":"10.1016\/j.mce.2016.04.004"},{"issue":"17","key":"10478_CR100","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1089\/ars.2015.6305","volume":"22","author":"MM Sung","year":"2015","unstructured":"Sung MM, Hamza SM, Dyck JRB (2015) Myocardial metabolism in diabetic cardiomyopathy: potential therapeutic targets. Antioxid Redox Signal 22(17):1606\u20131630","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"10478_CR101","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12933-019-0811-7","volume":"18","author":"Z Yin","year":"2019","unstructured":"Yin Z, Zhao Y, He M et al (2019) MiR-30c\/PGC-1\u03b2 protects against diabetic cardiomyopathy via PPAR\u03b1. Cardiovasc Diabetol 18(1):7","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10478_CR102","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1002\/ejhf.2741","volume":"24","author":"G van Woerden","year":"2022","unstructured":"van Woerden G, van Veldhuisen DJ, Westenbrink BD, de Boer RA, Rienstra M, Gorter TM (2022) Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives. Eur J Heart Fail 24(12):2238\u20132250","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10478_CR103","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/joim.12344","volume":"278","author":"AC Cordeiro","year":"2015","unstructured":"Cordeiro AC, Amparo FC, Oliveira MAC et al (2015) Epicardial fat accumulation, cardiometabolic profile and cardiovascular events in patients with stages 3\u20135 chronic kidney disease. J Intern Med 278(1):77\u201387","journal-title":"J Intern Med"},{"issue":"13","key":"10478_CR104","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.3390\/diagnostics13132157","volume":"13","author":"T Hogea","year":"2023","unstructured":"Hogea T, Noemi N, Suciu BA et al (2023) Increased epicardial adipose tissue and heart characteristics are correlated with bmi and predict silent myocardial infarction in sudden cardiac death subjects: an autopsy study. Diagnostics 13(13):2157","journal-title":"Diagnostics"},{"key":"10478_CR105","doi-asserted-by":"crossref","unstructured":"Iacobellis G, Leonetti F, Singh N, M Sharma A. Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. International Journal of Cardiology. 2007;115(2):272\u2013273.","DOI":"10.1016\/j.ijcard.2006.04.016"},{"issue":"2","key":"10478_CR106","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/antiox11020235","volume":"11","author":"J Guti\u00e9rrez-Cuevas","year":"2022","unstructured":"Guti\u00e9rrez-Cuevas J, Galicia-Moreno M, Monroy-Ram\u00edrez HC et al (2022) The role of NRF2 in obesity-associated cardiovascular risk factors. Antioxid 11(2):235","journal-title":"Antioxid"},{"issue":"1","key":"10478_CR107","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.rec.2017.12.007","volume":"72","author":"J Mar\u00ed-Alexandre","year":"2019","unstructured":"Mar\u00ed-Alexandre J, Barcel\u00f3-Molina M, Sanz-S\u00e1nchez J et al (2019) Thickness and an altered miRNA expression in the epicardial adipose tissue is associated with coronary heart disease in sudden death victims. Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition) 72(1):30\u201339","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"issue":"15","key":"10478_CR108","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1093\/cvr\/cvab367","volume":"118","author":"N Suffee","year":"2022","unstructured":"Suffee N, Baptista E, Piquereau J et al (2022) Impacts of a high-fat diet on the metabolic profile and the phenotype of atrial myocardium in mice. Cardiovasc Res 118(15):3126\u20133139","journal-title":"Cardiovasc Res"},{"key":"10478_CR109","doi-asserted-by":"crossref","unstructured":"Aguilar-Gallardo JS, Correa A, Contreras JP (2022) Cardio-renal benefits of sodium-glucose co-transporter 2 inhibitors in heart failure with reduced ejection fraction: mechanisms and clinical evidence. Eur Heart J Cardiovasc Pharmacother 8(3):311\u2013321","DOI":"10.1093\/ehjcvp\/pvab056"},{"key":"10478_CR110","doi-asserted-by":"crossref","unstructured":"Requena-Ib\u00e1\u00f1ez JA, Santos-Gallego CG, Rodriguez-Cordero A, et al (2021) Mechanistic insights of empagliflozin in nondiabetic patients with HFrEF. JACC: Heart Fail\u00a09(8):578\u2013589.","DOI":"10.1016\/j.jchf.2021.04.014"},{"key":"10478_CR111","doi-asserted-by":"crossref","unstructured":"Turgut C, Fernando J, Berry C, et al (2024) Effect of empagliflozin on epicardial adipose tissue volume in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF). Euro Heart J\u00a045(Supplement_1):ehae666.1018.","DOI":"10.1093\/eurheartj\/ehae666.1018"},{"issue":"8","key":"10478_CR112","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1001\/jamacardio.2019.2074","volume":"4","author":"RH Christensen","year":"2019","unstructured":"Christensen RH, Wedell-Neergaard A-S, Lehrskov LL et al (2019) Effect of aerobic and resistance exercise on cardiac adipose tissues. JAMA Cardiology 4(8):778","journal-title":"JAMA Cardiology"},{"issue":"8","key":"10478_CR113","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.biochi.2012.04.014","volume":"94","author":"E Distel","year":"2012","unstructured":"Distel E, Penot G, Cadoudal T, Balguy I, Durant S, Benelli C (2012) Early induction of a brown-like phenotype by rosiglitazone in the epicardial adipose tissue of fatty Zucker rats. Biochimie 94(8):1660\u20131667","journal-title":"Biochimie"},{"issue":"24","key":"10478_CR114","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1056\/NEJMoa072761","volume":"356","author":"SE Nissen","year":"2007","unstructured":"Nissen SE, Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356(24):2457\u20132471","journal-title":"N Engl J Med"},{"issue":"10","key":"10478_CR115","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1001\/jama.298.10.1189","volume":"298","author":"S Singh","year":"2007","unstructured":"Singh S, Loke YK, Furberg CD (2007) Long-term risk of cardiovascular events with rosiglitazone - a meta-analysis. Jama-J Am Med Assoc 298(10):1189\u20131195","journal-title":"Jama-J Am Med Assoc"},{"issue":"1","key":"10478_CR116","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12933-017-0528-4","volume":"16","author":"N Gonz\u00e1lez","year":"2017","unstructured":"Gonz\u00e1lez N, Moreno-Villegas Z, Gonz\u00e1lez-Bris A, Egido J, Lorenzo \u00d3 (2017) Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes. Cardiovasc Diabetol 16(1):44","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10478_CR117","doi-asserted-by":"publisher","first-page":"730","DOI":"10.2337\/dc10-2083","volume":"34","author":"HS Sacks","year":"2011","unstructured":"Sacks HS, Fain JN, Cheema P et al (2011) Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes. Diabetes Care 34(3):730\u2013733","journal-title":"Diabetes Care"},{"issue":"3","key":"10478_CR118","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s12020-015-0710-y","volume":"51","author":"MM Lima-Mart\u00ednez","year":"2015","unstructured":"Lima-Mart\u00ednez MM, Paoli M, Rodney M et al (2015) Effect of sitagliptin on epicardial fat thickness in subjects with type 2 diabetes and obesity: a pilot study. Endocrine 51(3):448\u2013455","journal-title":"Endocrine"},{"issue":"6","key":"10478_CR119","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.repc.2018.08.010","volume":"38","author":"M Ziyrek","year":"2019","unstructured":"Ziyrek M, Kahraman S, Ozdemir E, Dogan A (2019) Metformin monotherapy significantly decreases epicardial adipose tissue thickness in newly diagnosed type 2 diabetes patients. Rev Port Cardiol 38(6):419\u2013423","journal-title":"Rev Port Cardiol"},{"issue":"2","key":"10478_CR120","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/oby.21718","volume":"25","author":"G Iacobellis","year":"2017","unstructured":"Iacobellis G, Mohseni M, Bianco SD, Banga PK (2017) Liraglutide causes large and rapid epicardial fat reduction. Obesity 25(2):311\u2013316","journal-title":"Obesity"},{"issue":"1","key":"10478_CR121","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12933-017-0658-8","volume":"17","author":"T Sato","year":"2018","unstructured":"Sato T, Aizawa Y, Yuasa S et al (2018) The effect of dapagliflozin treatment on epicardial adipose tissue volume. Cardiovasc Diabetol 17(1):6","journal-title":"Cardiovasc Diabetol"},{"key":"10478_CR122","doi-asserted-by":"crossref","unstructured":"Randle Pj Fau - Garland PB, Garland Pb Fau - Hales CN, Hales Cn Fau - Newsholme EA, Newsholme Ea Fau - Denton RM, Denton Rm Fau - Pogson CI, Pogson CI. Interactions of metabolism and the physiological role of insulin.22(0079\u20139963 (Print)):1\u201348.","DOI":"10.1016\/B978-1-4831-9825-5.50004-X"},{"issue":"25","key":"10478_CR123","doi-asserted-by":"publisher","first-page":"22892","DOI":"10.1074\/jbc.M011647200","volume":"276","author":"C Lu","year":"2001","unstructured":"Lu C, Schwartzbauer G, Sperling MA et al (2001) Demonstration of direct effects of growth hormone on neonatal cardiomyocytes. J Biol Chem 276(25):22892\u201322900","journal-title":"J Biol Chem"},{"issue":"16","key":"10478_CR124","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.jacc.2022.08.738","volume":"80","author":"H Sorimachi","year":"2022","unstructured":"Sorimachi H, Obokata M, Omote K et al (2022) Long-term changes in cardiac structure and function following bariatric surgery. J Am Coll Cardiol 80(16):1501\u20131512","journal-title":"J Am Coll Cardiol"},{"key":"10478_CR125","doi-asserted-by":"crossref","unstructured":"Iacobellis G (2023) Epicardial fat links obesity to cardiovascular diseases. Prog Cardiovasc Dis\u00a078(1873\u20131740 (Electronic)):27\u201333.","DOI":"10.1016\/j.pcad.2023.04.006"},{"key":"10478_CR126","doi-asserted-by":"crossref","unstructured":"Lopaschuk GD, Verma S (2020) Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors. JACC Basic Transl Sci\u00a05(6):632\u2013644.","DOI":"10.1016\/j.jacbts.2020.02.004"},{"issue":"7","key":"10478_CR127","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.3390\/ijms21072641","volume":"21","author":"N Gandoy-Fieiras","year":"2020","unstructured":"Gandoy-Fieiras N, Gonzalez-Juanatey JR, Eiras S (2020) Myocardium metabolism in physiological and pathophysiological states: implications of epicardial adipose tissue and potential therapeutic targets. Int J Mol Sci 21(7):2641","journal-title":"Int J Mol Sci"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-024-10478-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-024-10478-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-024-10478-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T05:18:18Z","timestamp":1744348698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-024-10478-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":127,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["10478"],"URL":"https:\/\/doi.org\/10.1007\/s10741-024-10478-8","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"18 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}